Diabetes mellitus, type 2 Trials in Ayr, United Kingdom
Conditions / Diabetes mellitus, type 2 / Ayr, United Kingdom
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01467323 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01394952 | Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) | COMPLETED | PHASE3 |
| NCT01068665 | Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01520818 | Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes | COMPLETED | PHASE3 |
| NCT00331604 | Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes | TERMINATED | PHASE3 |
| NCT01042769 | A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT00700817 | The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT00331851 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00283751 | Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01885208 | Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |